ArticleJournal of medical cases2025
Successful Sentinel Lymph Node Biopsy in Accessory Breast Cancer.
Article in Journal of medical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Male accessory breast mucinous carcinoma: a case report and literature review.Discover oncology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary breast cancer occurring in accessory breast tissue is exceptionally rare, with an incidence of 0.2-0.6%. It can aggressively progress, often leading to early metastasis. Treatment is typically delayed due to the rarity, variety of differentials, and lack of clinical awareness of the disease. In axillary surgery, sentinel lymph node mapping in patients with axillary breast cancer is technically challenging and has been poorly described. Here, we present a case of a 53-year-old woman with a 0.5 × 1 cm hard lump in the right axillary region for 2 years, progressive growth for 6 months, and no concomitant breast lesion or axillary lymphadenopathy. Core needle biopsy revealed invasive ductal carcinoma with estrogen receptor and progesterone receptor expression and human epidermal growth factor receptor 2 negativity, whereas mammography and breast magnetic resonance imaging revealed no primary breast lesions. She was diagnosed with invasive cancer arising from an accessory breast and underwent wide total excision of the right accessory breast and sentinel lymph node biopsy. Sentinel lymph node biopsy can be successfully performed using intratumoral dye and subareolar radiocolloid mapping in accessory breast cancer surgery. Axillary accessory breast tissue is outside the scope of the screening breast examination; therefore, oncologists must be aware of this entity and associated pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.